Biolase shares drop 10.9%, Patterson Companies stock receives 'buy' rating & more: 6 key notes

 

Here are six key notes on dental companies from this past week.

1. Wall Street analysts project DENTSPLY will report earnings per share of $0.68 for the current fiscal quarter. The company recently reported earnings per share of $0.59 in May. This figure was 0.01 away from what analysts projected, according to the Markets Daily.

2. Henry Schein has a Zacks rating of "buy." This ranking is projected to change following its bleak second quarter 2015 report that was recently released. Henry Schein missed Zack's consensus estimate of $1.47 by a penny. The company posted revenues of $2.6 billion, according to Zacks.

3. Biolase shares dropped 10.9 percent during the last week and dropped 21.1 percent in the last four weeks. The shares are negative opposed to the S&P 500 for the past week with a reported loss of 8.6 percent. The company has underperformed the index by 20.3 percent in the last four weeks, according to NWI.

4. Danaher CEO Thomas Patrick Joyce, Jr. sold 25,300 shares of Danaher stock on Friday, June 24 for a total value of $2.3 million. The stock sold at an average price of $88.20, according to Sleek Monkey.

5. 3M Company shares traded negative at $14.82 with the price dropping 0.06 percent. The company's net money flow was $9.2 million, according to the Insider Trading Report.

6. Patterson Companies stock was upgraded from a "hold" rating to a "buy" rating by Zacks. The company presently has a $55.00 price objective on the stock, according to Dakota Financial News.

More dental news:
Texas bill requires registration of dental support organizations — 8 notes
5 notes on Dr. Kourosh Maddahi and the 'Smile Lift'
The Roman solider and the modern dentist: How the valuation of serving Caesar is similar to valuing your dental practice

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

New From Becker's Dental Review

Aspen Dental, Henry Schein & more: 7 dental companies making headlines

Read Now